Revolution Medicines, Inc. (NASDAQ:RVMD – Get Rating) has been assigned an average rating of “Moderate Buy” from the eight research firms that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year target price among […]
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 15, 2022, the Board of. | December 19, 2022